butabarbital decreases consequences of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Intently. Coadministration of CYP3A4 inducers may lower sufentanil concentrations and efficacy, perhaps precipitating withdrawal syndrome in patients that have formul